Related Experiment Videos
[Frey syndrome]
A Bremerich1, H Eufinger, J Rustemeyer
1Klinik für Mund-, Kiefer- und Gesichtschirurgie, Zentralkrankenhaus St.-Jürgen-Strasse, 28205 Bremen.
Mund-, Kiefer- Und Gesichtschirurgie : MKG
|March 29, 2001
Summary
Frey's syndrome (gustatory sweating) affects 23.5% of patients post-parotidectomy. Scopolamine ointment showed no significant benefit over no treatment for this common complication.
Area of Science:
- Otolaryngology
- Head and Neck Surgery
- Facial Nerve Surgery
Background:
- Frey's syndrome, characterized by gustatory sweating, is a known complication following parotidectomy.
- The reported incidence and effective treatment strategies for Frey's syndrome vary in existing literature.
Purpose of the Study:
- To determine the incidence of Frey's syndrome after parotidectomy.
- To evaluate the efficacy of scopolamine ointment in treating Frey's syndrome.
Main Methods:
- A retrospective analysis of 372 parotidectomies performed between 1980 and 1994.
- Assessment of symptom development and treatment outcomes in 86 patients diagnosed with Frey's syndrome.
Main Results:
- Frey's syndrome developed in 23.5% (86/364) of patients post-parotidectomy.
- Scopolamine ointment treatment in 35 patients showed limited improvement (9 cases) and was not significantly better than no treatment (7/20 improved).
- Average follow-up was 18 months for symptom development and 20-25 months for treatment outcomes.
Conclusions:
- Frey's syndrome remains a challenging post-parotidectomy complication.
- Current evidence suggests scopolamine ointment is not a significantly effective treatment for Frey's syndrome.